2-Naphthacenecarboxamide,11a-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-3,10,12,12a-tetrahydroxy-6-methylene-1,5,11-trioxo-,monohydrofluoride (61850-57-5)

Identification
Name:	2-Naphthacenecarboxamide,11a-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-3,10,12,12a-tetrahydroxy-6-methylene-1,5,11-trioxo-,monohydrofluoride
CAS:	61850-57-5
Molecular Structure:
Properties
Safety Data

Other Product

2-Naphthacenecarboxamide, 11a-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-3,5,10,12a-tetrahydroxy-6-methylene-1,11,12-trioxo-, [4S-(4α,4aα,5α,5aα,11aβ,12aα)]-
2-Naphthacenecarboxamide,11a-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-3,5,10,12a-tetrahydroxy-6-methylene-1,11,12-trioxo-
2-Naphthacenecarboxamide,11a-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-3,10,12,12a-tetrahydroxy-6-methylene-1,5,11-trioxo-, monoperchlorate(salt)
2-Naphthacenecarboxamide, 11a-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-3,5,10,12a-tetrahydroxy-6-methylene-1,11,12-trioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,11aalpha,12aalpha))-, mono(4-methylbenzenesulfonate) (salt)
l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5α,5aα,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide (1:1)
Sulfamic acid, hexyl-, compd. with [4S-(4α,4aα,5α,5aα,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide (1:1)
Sulfuric acid, monododecyl ester, compd. with [4S-(4α,4aα,5α,5aα,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide (1:1)
Urs-20-en-28-oic acid,12-hydroxy-3-(4-hydroxyphenoxy)-11-methoxy-, (3b,11a,12a)- (9CI)
l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5α,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5α,5aα,6β,12aα)]-
l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
b-D-Galactopyranoside, (3b,4a,11a,16b,21a)-16,21,23,28-tetrahydroxy-11-methoxyolean-12-en-3-ylO-b-D-glucopyranosyl-(1®2)-O-[b-D-glucopyranosyl-(1®3)]-6-deoxy- (9CI)
Metaphosphoric acid (HPO3), compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (4:3), monosodium salt
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
b-D-Galactopyranoside, (3b,4a,11a,16b)-16,23,28-trihydroxy-11-methoxyolean-12-en-3-ylO-6-deoxy-a-L-mannopyranosyl-(1®4)-O-b-D-glucopyranosyl-(1®3)-O-[b-D-glucopyranosyl-(1®2)]-6-deoxy- (9CI)
b-D-Galactopyranoside, (3b,4a,11a)-23,28-dihydroxy-11-methoxyolean-12-en-3-yl O-6-deoxy-a-L-mannopyranosyl-(1®4)-O-b-D-glucopyranosyl-(1®3)-O-[b-D-glucopyranosyl-(1®2)]-6-deoxy-
11a-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,11a,12,12a-decahydro-3,5,10,12a-tetrahydroxy-6-methylene-1,11,12-trioxonaphthacene-2-carboxamide hydrochloride
b-D-Galactopyranoside, (3b,4a,11a,16b)-16,23,28-trihydroxy-11-methoxyolean-12-en-3-ylO-b-D-glucopyranosyl-(1®2)-O-[O-b-D-xylopyranosyl-(1®4)-b-D-glucopyranosyl-(1®3)]-6-deoxy- (9CI)
(1'S,2S,3R,3a'S,4b'R,5S,5''S,6a'S,9a'S,9b'S,11'R,11a'R,11b'S,12'S,14a'S,15b'R,17a'S,20a'S,20b'S,22'R,22a'R,22b'S)-5-(hydroxymethyl)-1',5,5'',9a',11a',12',20a',22a'-octamethyl-3'',3a',4,4'',4b',5,5',5'',6',6'',6a',7',9',9a',9b',10',11',11a',14a',15b',16',1
1/C12H17NO2/c14-11-4-2-1-3-9(11)7-10-8-12(5-6-12)15-13-10/h9H,1-8H